Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print

Industry News

Related Searches:

Filter by:

June 20, 2007
The U.S. District Court for the Southern District of New York has upheld the patent for the API of Plavix, allowing Bristol-Myers Squibb and Sanofi-Aventis to retain exclusivity of the antiplatelet drug through November 2011. The companies were battl…   Read More »
June 20, 2007
CuraGen Corp. will close its pilot manufacturing plant, effective July 27, 2007. As a result, the company will reduce its workforce by approximately 40 employees, primarily composed of preclinical and manufacturing researchers, and additional support…   Read More »
June 20, 2007
Althea Technologies has been contracted by GeoVax Labs to manufacture its HIV-1 DNA (AIDS) vaccine. This vaccine will be utilized in GeoVax's Phase II trials, which are planned to start in early 2008. GeoVax chose Althea as the contract manufacturer…   Read More »
June 19, 2007
Parexel International has opened a new location in Hyderabad, India. Through this new location, PAREXEL "offers its clients a wide range of clinical research and data management services while deepening its long-term commitment in India," a…   Read More »
June 18, 2007
Aptuit, Inc. and Laurus Labs Ltd. have formed a new contract drug development company, Aptuit Laurus, which will combine Aptuit's global offerings in drug development with Laurus' R&D and manufacturing expertise and new state-of-the-art facilitie…   Read More »
June 15, 2007
MedImmune, Inc. has been awarded a contract from the U.S. Department of Health and Human Services (HHS) to modify its U.S. vaccine manufacturing facilities to produce pandemic influenza vaccines using its live, attenuated, needle-free technology. The…   Read More »
June 15, 2007
Thermo Fisher Scientific, Inc. has entered a strategic partnership with Megaware, a life science technology organization, to deliver a new bioanalysis/equivalence solution and joint support services for pharma, biopharma and CROs. Under the term…   Read More »
June 14, 2007
ProNAi Therapeutics, Inc. has signed a supply agreement with Polymun Scientific GmbH, an Austrian contract biopharmaceutical developer, to manufacture the company's PNT2258 DNAi-based cancer therapeutic. Under the terms of the agreement, Polymun…   Read More »
June 13, 2007
Pharmacopeia will receive $5 million payment from GlaxoSmithKline in connection with two companies' product development and commercialization agreement from March 2006. This is the second $5 million payment Pharmacopeia has received. This paym…   Read More »
June 13, 2007
The global pharmaceutical market will more than double in value to $1.3 trillion by 2020, according a PricewaterhouseCoopers report, entitled Pharma 2020: The Vision - Which Path Will You Take? The factors influencing this estimate include increasing…   Read More »
June 12, 2007
Jacobs Engineering Group, Inc. received a contract from Wyeth Medica Ireland to provide design and construction management services for a new pilot scale lab facility at the Grange Castle site, Clondalkin, Ireland. The development includes expanding…   Read More »
June 8, 2007
Akorn, Inc. has added two injectable drug products to its API Supply and Margin Sharing Agreement with Natco Pharma Ltd. One of the ANDA drug products is for the prevention of nausea and vomiting associated with cancer chemotherapy, and the other pro…   Read More »
June 7, 2007
Genzyme Corp. plans to build a new biomanufacturing plant in Lyon, France, for the production of Thymoglobulin, a treatment used in transplantation, in order to meet the anticipated long-term demand for the drugs current and potential new indications…   Read More »
June 7, 2007
Amgen will acquire Alantos, a private company developing drugs for diabetes and inflammatory diseases, for $300 million in cash. Alantos' lead drug candidate, ALS 2-0426, is a DPP-IV inhibitor in Phase IIa development for the treatment of type II dia…   Read More »
June 7, 2007
Intertek Group has acquired Quantitative Technologies Inc. (QTI), a contract analytical research and development laboratory. QTI has served the North American market for more than 15 years, specializing in the pre-market launch stages of the drug and…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On